Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis

European Journal of Cancer Part A

Volumn 32, Issue 7, 1996, Pages 1209-1214

  Musarrat, J ^a   Arezina Wilson, J ^a   Wani, A A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b 103 Wiseman Hall ^*  (United States)

Author keywords

8 hydroxydeoxyguanosine; breast cancer; immunodetection; oestrogen receptor; oxidative DNA damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ESTROGEN RECEPTOR;

ARTICLE; BREAST CARCINOGENESIS; BREAST DUCT; CANCER INCIDENCE; CANCER RISK; DNA ADDUCT; DNA DAMAGE; DNA SYNTHESIS INHIBITION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; SOLID PHASE EXTRACTION;

EID: 0030176396     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00031-7     Document Type: Article

References (32)

1. 1. Pasqualine JR. Breast cancer, present and future. J Steroid Biochem Mol Biol 1994, 51, V-VI.
2. 2. Kuchino Y, Mori F, Kasai H, et al. Misreading of DNA template containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residue. Nature 1987, 327, 77-79.
3. 3. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation damaged base 8-hydroxyguanine. Nature 1991, 349, 431-434.
4. 4. Wood ML, Dizdaroglu M, Gajewski E, Essigmann JM. Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry 1990, 29, 7024-7032.
5. 5. Kasai H, Nishimura S, Kurokawa Y, Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 1987, 8, 1959-1961.
6. 6. Umemura T, Sai K, Takagi A, Hasegawa R, Kurokawa Y. Formation of 8-hydroxyguanosine (8-OHdG) in rat kidney DNA after intraperitoneal administration of ferric nitrilo-triacetate (Fe-NTA). Carcinogenesis 1990, 11, 345-347.
7. 7. Floyd RA. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990, 11, 1447-1450.
8. 8. Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A, Tanooka H. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 1986, 7, 1849-1851.
9. 9. Malins DC, Haimanot R. Major alterations in the nucleotide structure in DNA in cancer of the female breast. Cancer Res 1991, 51, 5430-5432.
10. 10. Nagashima M, Tsuda H, Takenoshita S, et al. 8-hydroxydeoxyguanosine levels in DNA of human breast cancers are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. Cancer Lett 1995, 90, 157-162.
11. 11. Klijn JG, Foekens JA. In Goldhirsch A, ed. Endocrine Treatment of Breast Cancer IV. Monograph Series of the European School of Oncology. Berlin, Springer, 1990, 17.
12. 12. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2′-deoxyguanosine as a biomarker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 1989, 86, 9697-9701.
13. 13. Dizdaroglu M. Chemical determination of free radical induced damage to DNA. Free Radic Res Commun 1991, 10, 225-242.
14. 14. Ames BN. Endogenous DNA damage as related to cancer and aging. Mutat Res 1989, 214, 41-46.
15. 15. Cesarone CF, Bolognesi C, Santi C. Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem 1979, 100, 188-197.
16. 16. Venkatachalam S, Denissenko MF, Alvi N, Wani AA. Rapid activation of apoptosis in human promyelocytic leukemia cells by (±)-anti-benzo[a]pyrene-diol epoxide induced DNA damage. Biochem Biophys Res Commun 1993, 197, 722-729.
17. 17. Musarrat J, Wani AA. Quantitative immunoanalysis of promutagenic 8-hydroxy-2′-deoxyguanosine in oxidized DNA. Carcinogenesis 1994, 15, 2037-2043.
18. 18. Wani AA, Sullivan JK, Lebowitz J. Immunoassays for carbodiimide modified DNA-detection of unpairing transitions in supercoiled ColE1 DNA. Nucleic Acids Res 1989, 17, 9957-9977.
19. 19. Lu Y, Trush MA, Yager JD. DNA damage caused by reactive oxygen species originating from a copper dependent oxidation of the 2-hydroxy catechol of estrodiol. Carcinogenesis 1994, 15, 1421-1427.
20. 20. Sanchez-Ramos JR, Övervik E, Ames BN. A marker of oxyradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration 1994, 3, 197-204.
21. 21. Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science 1991, 254, 1131-1138.
22. 22. Key TJ, Pike MC. The role of estrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988, 24, 29-43.
23. 23. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 1986, 83, 2496-2500.
24. 24. Linder MC. Nutritional Biochemistry and Metabolism. New York, Elsevier, 1991.
25. 25. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990, 87, 4533-4537.
26. 26. Fleming ID, Fleming MD. Breast cancer in elderly women. Cancer 1994, 74 (Suppl.), 2160-2164.
27. 27. Malins DC, Holmes EH, Polissar NL, Gunselman SJ. The etiology of breast cancer: characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993, 71, 3036-3043.
28. 28. London SJ, Colditz GA, Stampfer MJ, Willet WC, Rosner BA, Speizer FE. Prospective study of smoking and the risk of breast cancer. J Natl Cancer Inst 1989, 81, 1625-1631.
29. 29. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull 1993, 49, 523-544.
30. 30. Hinds PW, Linlay CA, Quartin RS, et al. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth Differ 1990, 1, 571-580.
31. 31. Seth A, Palli D, Mariano JM, et al. p53 gene mutations in women with breast cancer and a previous history of benign breast disease. Eur J Cancer 1994, 30A, 808-812.
32. 32. Glebov OK, McKenzie KE, White CA, Sukumar S. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res 1994, 54, 3703-3709.